Tolvaptan Tablets (RLD Jynarque®) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023), said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results